We are live on ! Find out more
VECT

VectivBio Holding AG Ordinary Shares
VECT

Delisted

VECT was delisted on the 7th of July, 2023.

Back to rankings

26 hedge funds and large institutions have $270M invested in VectivBio Holding AG Ordinary Shares in 2021 Q2 according to their latest regulatory filings, with 26 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
26
Holders Change
+26
Holders Change %
–
% of All Funds
0.45%
Holding in Top 10
2
Holding in Top 10 Change
+2
Holding in Top 10 Change %
% of All Funds
0.03%
New
26
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
O
OrbiMed
New York
+$77.8M
2
NHAS
Novo Holdings A/S
Denmark
+$53.5M
3
B
Bpifrance
France
+$42.6M
4
Citadel Advisors
Citadel Advisors
Florida
+$41.4M
5
CA
CHI Advisors
New York
+$39.3M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
O
1
OrbiMed
New York
$59.7M +$77.8M +5,123,304 New
NHAS
2
Novo Holdings A/S
Denmark
$41.1M +$53.5M +3,522,019 New
B
3
Bpifrance
France
$32.7M +$42.6M +2,806,217 New
Citadel Advisors
4
Citadel Advisors
Florida
$31.2M +$41.4M +2,725,767 New
CA
5
CHI Advisors
New York
$30.2M +$39.3M +2,585,986 New
EAM
6
Eventide Asset Management
Massachusetts
$26.6M +$35.5M +2,341,427 New
CAM
7
Cormorant Asset Management
Massachusetts
$25.5M +$33.8M +2,226,128 New
PHS
8
PFM Health Sciences
California
$7.13M +$9.28M +611,074 New
DCM
9
Driehaus Capital Management
Illinois
$5.32M +$6.92M +456,016 New
UBS Group
10
UBS Group
Switzerland
$3.01M +$3.92M +258,464 New
TCM
11
Tekla Capital Management
Massachusetts
$1.69M +$2.2M +145,000 New
Millennium Management
12
Millennium Management
New York
$1.11M +$1.45M +95,214 New
WP
13
Woodline Partners
California
$1.01M +$1.31M +86,596 New
NMC
14
NEA Management Company
Maryland
$782K +$1.02M +67,069 New
MIM
15
Monashee Investment Management
Massachusetts
$635K +$827K +54,466 New
Jane Street
16
Jane Street
New York
$633K +$824K +54,254 New
CCM
17
CAAS Capital Management
New York
$479K +$624K +41,096 New
PCM
18
Pinz Capital Management
New York
$356K +$464K +30,561 New
Squarepoint
19
Squarepoint
New York
$292K +$380K +25,000 New
Geode Capital Management
20
Geode Capital Management
Massachusetts
$207K +$270K +17,780 New
Northern Trust
21
Northern Trust
Illinois
$83K +$109K +7,159 New
Wells Fargo
22
Wells Fargo
California
$43K +$56.1K +3,696 New
TRCT
23
Tower Research Capital (TRC)
New York
$4K +$5.25K +346 New
EBA
24
Eagle Bay Advisors
New York
$2K +$1.52K +100 New
Bank of America
25
Bank of America
North Carolina
– +$15 +1 New
1
2

VECT Hedge Fund Activity: Q2 2021 in Review

26 of the 5,746 institutional investors tracked by Wall St. Rank reported a position in VectivBio Holding AG Ordinary Shares (VECT) for Q2 2021, worth a combined $270M.

Buyers outnumbered sellers: 26 funds opened new VECT positions and 0 closed out — a net gain of 26 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was OrbiMed, opening a new position worth an estimated $77.8M.

  • 26 institutional investors held VectivBio Holding AG Ordinary Shares (VECT) as of Q2 2021, up from 0 in Q1 2021.
  • Funds reported $270M of VectivBio Holding AG Ordinary Shares stock for Q2 2021.
  • 26 funds opened new VectivBio Holding AG Ordinary Shares positions in Q2 2021 and 0 closed out, a net change of +26 holders.
  • The largest VectivBio Holding AG Ordinary Shares buyer in Q2 2021 was OrbiMed, an estimated $77.8M added.

Based on aggregated 13F filings for Q2 2021.